Research Use Only

ClinAI™ Prostate

The advanced AI solution for diagnosis, Gleason scoring, and outcome-based risk prediction.

Core Capabilities

Diagnosis & Scoring

Automated detection & extent of cancer, Gleason grading, perineural invasion and cribriform morphologies.

Risk Prediction

Outcome based risk prediction of relapse (BCR)

Treatment Response

Under development.

For Pharmaceutical Companies & Labs

ClinAI™ offers a robust "Research Use Only" (RUO) solution designed for:

  • Private Pathology Laboratories: Increase throughput and consistency in diagnosis.
  • Pharmaceutical Companies: enhance clinical trials with precise patient stratification based on risk and predicted outcome.

Contact

< 5 min

Analysis time per case

96%

Sensitivity for cancer detection